Difference between revisions of "Macleod 2014 Lancet"
From Bioblast
m (Iglesias-Gonzalez Javier moved page Macleod 2014 to Macleod 2014 Lancet) |
|
(No difference)
| |
Revision as of 22:51, 25 January 2021
| Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioanidis JPA, Salman RAS, Chan AW, Glasziou P (2014) Biomedicel research: increasing value, reducing waste.. Lancet 383(9912):101-4. |
Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioanidis JPA, Salman RAS, Chan AW, Glasziou P (2014) Lancet
Abstract: Of 1575 reports about cancer prognostic markers published in 2005, 1509 (96%) detailed at least one significant prognostic variable. However, few identifi ed biomarkers have been confirmed by subsequent research and few have entered routine clinical practice. This pattern—initially promising findings not leading to improvements in health care—has been recorded across biomedical research. So why is research that might transform health care and reduce health problems not being successfully produced?
• Bioblast editor: Iglesias-Gonzalez J
Labels:
Publication efficiency, MitoFit 2021 PT
